TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Cand Pharm C. Cristoffersen AS
Closing information (x1000 DKK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
168,648
|
160,527
|
147,583 |
| Financial expenses |
43
|
129
|
353 |
| Earnings before taxes |
16,801
|
22,079
|
15,903 |
| Total assets |
89,710
|
85,494
|
69,776 |
| Current assets |
81,000
|
75,562
|
57,765 |
| Current liabilities |
27,659
|
29,396
|
23,702 |
| Equity capital |
62,050
|
56,099
|
46,073 |
| - share capital |
1,766
|
1,864
|
1,769 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
69.2%
|
65.6%
|
66.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
10.0%
|
13.8%
|
10.8% |
| Return on assets (ROA) |
18.8%
|
26.0%
|
23.3% |
| Current ratio |
292.9%
|
257.0%
|
243.7% |
| Return on equity (ROE) |
27.1%
|
39.4%
|
34.5% |
| Change turnover |
16,553
|
4,992
|
19,454 |
| Change turnover % |
11%
|
3%
|
15% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.